A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Clinical trial NCT07139548 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07139548
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2026-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.